With Fermion, start the journey of your innovative API.
01 1Fermion Oy
02 1Fresenius Kabi Oncology Ltd.
03 1Jiangsu Hengrui Pharmaceuticals Co. , Ltd.
04 1Olon S. p. A.
05 2ScinoPharm Taiwan, Ltd.
06 1Shandong Anxin Pharmaceutical Co. , Ltd.
07 1Shanghai Desano Chemical Pharmaceutical Co. , Ltd.
08 2Sichuan Cooperation Pharmaceutical Co., Ltd.
With Fermion, start the journey of your innovative API.
Irinotecan hydrochloride hydrate
Registration Number : 220MF10025
Registrant's Address : Koivu-Mankkaan tie 6A, FI-02200 Espoo, Finland
Initial Date of Registration : 2008-01-23
Latest Date of Registration : 2021-07-20
A Irinotecan Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Irinotecan Hydrochloride, including repackagers and relabelers. The FDA regulates Irinotecan Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Irinotecan Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Irinotecan Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Irinotecan Hydrochloride supplier is an individual or a company that provides Irinotecan Hydrochloride active pharmaceutical ingredient (API) or Irinotecan Hydrochloride finished formulations upon request. The Irinotecan Hydrochloride suppliers may include Irinotecan Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Irinotecan Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Irinotecan Hydrochloride Drug Master File in Japan (Irinotecan Hydrochloride JDMF) empowers Irinotecan Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Irinotecan Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Irinotecan Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Irinotecan Hydrochloride suppliers with JDMF on PharmaCompass.
We have 8 companies offering Irinotecan Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
